JP2000086506A - Production of granule containing teprenone - Google Patents

Production of granule containing teprenone

Info

Publication number
JP2000086506A
JP2000086506A JP10258218A JP25821898A JP2000086506A JP 2000086506 A JP2000086506 A JP 2000086506A JP 10258218 A JP10258218 A JP 10258218A JP 25821898 A JP25821898 A JP 25821898A JP 2000086506 A JP2000086506 A JP 2000086506A
Authority
JP
Japan
Prior art keywords
granules
teprenone
pts
spray
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10258218A
Other languages
Japanese (ja)
Other versions
JP4226116B2 (en
Inventor
Katsuhiro Nakamura
雄啓 中村
Eishin Ando
英信 安藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP25821898A priority Critical patent/JP4226116B2/en
Publication of JP2000086506A publication Critical patent/JP2000086506A/en
Application granted granted Critical
Publication of JP4226116B2 publication Critical patent/JP4226116B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glanulating (AREA)

Abstract

PROBLEM TO BE SOLVED: To efficiently obtain the subject granules by allowing granules to adsorb teprenone, wherein the granules are obtained by dissolving lactose, mannitol, silicon dioxide and a water-soluble binder in water and subsequently spray- drying the solution. SOLUTION: The granules containing teprenone are preferably obtained by dissolving (A) 500-1,000 pts.wt. of lactose, (B) 700-1,500 pts.wt. of mannitol, (C) 100-500 pts.wt. of silicon dioxide and (D) 50-150 pts.wt. of a water-soluble binder (for example, hydroxypropylcellulose) in 2,000 pts.wt. of water, spray- drying the obtained solution in 100-300 deg.C hot air to prepare granules, and subsequently allowing the granules to adsorb (E) the teprenone (chemical name: 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraene-2-one). The component E is preferably adsorbed in an amount of 100 pts.wt. to 700-1,500 pts.wt. of the granules obtained by the above spray drying treatment.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、テプレノン含有顆粒の
製造方法に関する。
The present invention relates to a method for producing teprenone-containing granules.

【0002】[0002]

【発明の背景及び従来技術】テプレノンは、胃炎・胃潰
瘍の治療剤として広く用いられている。テプレノンは常
温で液体の油状物質であるため、製剤化にあたっては吸
油能のある粉体にテプレノンを吸着することにより細粒
剤又はカプセル剤としている。細粒剤とするには通常、
乳糖、デンプン等の賦形剤を転動造粒装置又は流動層造
粒装置により混合し、ポリビニルピロリドン等の結合剤
を溶解した水溶液を徐々に添加しながら造粒を行い、乾
燥後、更にテプレノンを徐々に加えて吸着する方法が用
いられる。
Background of the Invention and Prior Art Teprenone is widely used as a therapeutic agent for gastritis and gastric ulcer. Since teprenone is an oily substance that is liquid at normal temperature, it is made into fine granules or capsules by adsorbing teprenone on a powder having an oil-absorbing ability during formulation. To make it into fine granules,
Lactose, excipients such as starch are mixed by a tumbling granulator or a fluidized bed granulator, and granulation is performed while gradually adding an aqueous solution in which a binder such as polyvinylpyrrolidone is dissolved. Is gradually added for adsorption.

【0003】[0003]

【発明が解決しようとする課題】従来用いられる方法
は、賦形剤の造粒とテプレノンの吸着を同一の製剤機械
により、連続して行えるという利点があるが、製剤機械
の大きさには制限があり、一回あたりの生産量が限られ
ていることからコストの低減に関して難点があった。本
発明者は、現行のテプレノン含有細粒剤と同等の品質を
保ちつつコストを低減する製造方法を鋭意検討した結
果、以下に示す方法により課題を解決できることを見出
し本発明を発明した。
The method used in the prior art has the advantage that granulation of excipients and adsorption of teprenone can be performed continuously by the same preparation machine, but the size of the preparation machine is limited. However, there is a problem in terms of cost reduction due to the limited amount of production per operation. As a result of intensive studies on a manufacturing method for reducing the cost while maintaining the same quality as that of the current teprenone-containing fine granule, the present inventors have found that the problems can be solved by the following method, and have invented the present invention.

【0004】[0004]

【課題を解決するための手段】本発明は、乳糖、マンニ
トール、二酸化ケイ素及び水溶性結合剤を水に溶解後噴
霧乾燥して得られた顆粒に、テプレノンを吸着すること
を特徴とするテプレノン含有顆粒の製造方法である。本
発明におけるテプレノンとは、化学名6,10,14,18-テト
ラメチル-5,9,13,17-ノナデカテトラエン-2-オンであ
り、通常は5位のシストランスが3:2の混合物である
が、テプレノンはその構造上8種の幾何異性体が存在
し、本発明においては異性体には特に制限はない。テプ
レノンは酸化に対して不安定であるため、ビタミンE等
の抗酸化剤を配合しておくことが好ましい。
DISCLOSURE OF THE INVENTION The present invention comprises a method of adsorbing teprenone to granules obtained by dissolving lactose, mannitol, silicon dioxide and a water-soluble binder in water and then spray-drying the resulting mixture. This is a method for producing granules. Teprenone in the present invention is a chemical name of 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one, and usually, cis trans at the 5-position is 3: 2. In the present invention, there are eight types of geometric isomers of teprenone, and isomers are not particularly limited in the present invention. Since Teprenone is unstable to oxidation, it is preferable to add an antioxidant such as Vitamin E.

【0005】本発明における乳糖、マンニトールは日本
薬局方に収載されている汎用賦形剤であり、市販のもの
を容易に入手できる。二酸化ケイ素は、軽質無水ケイ酸
として日本薬局方に収載されており、商品名「サイリシ
ア」等として容易に入手できる。結合剤は、賦形剤等を
造粒する際の「のり」の役割を果たすものであるが、本
発明においては水溶性の結合剤が好ましく、具体的には
ヒドロキシプロピルセルロース、ポリビニルピロリド
ン、ヒドロキシプロピルメチルセルロース等を挙げるこ
とができる。
[0005] Lactose and mannitol in the present invention are general-purpose excipients listed in the Japanese Pharmacopoeia, and are readily available commercially. Silicon dioxide is listed in the Japanese Pharmacopoeia as light anhydrous silicic acid, and can be easily obtained under the trade name “thyricia” or the like. The binder plays a role of “paste” when granulating excipients and the like. In the present invention, a water-soluble binder is preferable, and specifically, hydroxypropyl cellulose, polyvinylpyrrolidone, hydroxy Propylmethylcellulose and the like can be mentioned.

【0006】本発明における、噴霧乾燥液中の各成分の
濃度は、水2000重量部に対し、乳糖500〜100
0重量部、マンニトール700〜1500重量部、二酸
化ケイ素100〜500重量部及び水溶性結合剤50〜
150重量部である。各成分を含有した溶液は所望量を
秤取後、水に溶解懸濁して容易に得ることができる。
In the present invention, the concentration of each component in the spray-dried liquid is 500 to 100 parts by weight of lactose per 2,000 parts by weight of water.
0 parts by weight, 700-1500 parts by weight of mannitol, 100-500 parts by weight of silicon dioxide, and 50-
It is 150 parts by weight. A solution containing each component can be easily obtained by weighing out a desired amount and then dissolving and suspending in water.

【0007】本発明における噴霧乾燥の方法は特に限定
されずディスク法、ノズル法等いずれも用いることがで
きる。噴霧乾燥機内に導入する熱風温度は特に限定され
ないが、通常約100℃〜約300℃である。温度は、
溶液の噴霧量と、噴霧乾燥顆粒の所望の乾燥減量を得る
ために適宜選択できる。噴霧乾燥機からの熱風の出口温
度(排風温度)は通常約100℃〜約150℃である。
噴霧乾燥機は、大型の方がコスト低減には有利であり、
また、連続して噴霧乾燥できる装置を用いる方が有利で
ある。噴霧乾燥して得られた顆粒にテプレノンを吸着す
るには、流動層装置等の普通に用いられる装置を用い
る。テプレノンと噴霧乾燥顆粒の比率は、テプレノン1
00重量部に対し、噴霧乾燥顆粒700〜1500重量
部である。
The spray drying method in the present invention is not particularly limited, and any of a disk method, a nozzle method and the like can be used. The temperature of the hot air introduced into the spray dryer is not particularly limited, but is usually about 100 ° C to about 300 ° C. The temperature is
It can be appropriately selected to obtain the spray amount of the solution and the desired loss on drying of the spray-dried granules. The outlet temperature of hot air from the spray dryer (exhaust air temperature) is usually about 100C to about 150C.
Spray dryers are more advantageous for cost reductions,
Further, it is more advantageous to use an apparatus that can continuously spray-dry. In order to adsorb teprenone to the granules obtained by spray drying, a commonly used apparatus such as a fluidized bed apparatus is used. The ratio of teprenone to spray-dried granules is 1
The spray-dried granules are 700 to 1500 parts by weight based on 00 parts by weight.

【0008】本発明において顆粒とは、流動性の良好な
粉末より大きな粒子を意味しその粒子径は特に制限され
ないが、例えば、日本薬局方における顆粒が本発明の顆
粒剤の目安となる。本発明においてはいわゆる細粒剤も
顆粒剤に含まれる。
[0008] In the present invention, granules mean particles larger than a powder having good flowability, and the particle size thereof is not particularly limited. For example, granules in the Japanese Pharmacopoeia serve as a standard of the granules of the present invention. In the present invention, so-called fine granules are also included in the granules.

【0009】本発明におけるテプレノン含有顆粒の製法
を例を挙げて説明する。水溶性結合剤であるヒドロキシ
プロピルセルロース100g、無水ケイ酸水加物である
サイリシア(商品名)250g、D−マンニトール11
20gおよび乳糖100gを水2200gに溶解・懸濁
させた後、排風温度120〜150℃で、スプレードラ
イし顆粒剤を得る。次に得られた顆粒剤を流動層乾燥機
に移し、テプレノンを噴霧してテプレノン含有顆粒を得
ることができる。
The method for producing teprenone-containing granules in the present invention will be described with reference to examples. 100 g of hydroxypropylcellulose as a water-soluble binder, 250 g of Sylysia (trade name) as a silicic acid hydrate, D-mannitol 11
After dissolving and suspending 20 g and lactose 100 g in 2200 g of water, it is spray-dried at an exhaust air temperature of 120 to 150 ° C. to obtain granules. Next, the obtained granules are transferred to a fluidized bed dryer, and teprenone is sprayed to obtain teprenone-containing granules.

【0010】[0010]

【効果】本発明によるテプレノン含有顆粒は、従来法に
よる顆粒剤より低コストで製造できる。これは本発明に
よる方法が、工程数が少なく、またスケールを大きくで
き、更に噴霧乾燥顆粒を連続生産できるためである。例
えば、従来法による顆粒剤においては、テプレノンを吸
着前の顆粒剤を得るのに、混合、一次造粒、二次造粒、
乾燥、整粒、解砕、整粒の7工程が必要であったが、本
発明においては溶解・懸濁、噴霧乾燥、篩別の3工程で
済み、また、生産スケールは、従来法は1回の処理あた
り約150kgであったが、本発明における噴霧乾燥顆
粒は1回2000kg以上の製造が可能であり、装置に
よっては連続生産が可能である。本発明においては、噴
霧乾燥顆粒を得る工程とテプレノンを吸着する工程が連
続しておらず、別の製造機械を使用しなければならない
ため、従来この様な製造方法を試みることはなかった。
本発明者は、より効率的な製造方法を鋭意検討したとこ
ろ、従来試みられることのなかった不連続な製造方法の
方が、工数、コスト等の点で以外にも従来法より優れて
おり、しかも品質は同等であることを見出し本発明を完
成したものである。
The granules containing teprenone according to the present invention can be produced at lower cost than the granules prepared by the conventional method. This is because the method according to the present invention has a small number of steps, a large scale, and a continuous production of spray-dried granules. For example, in the granules according to the conventional method, in order to obtain granules before adsorption of teprenone, mixing, primary granulation, secondary granulation,
Although seven steps of drying, sizing, crushing, and sizing were necessary, in the present invention, three steps of dissolution / suspension, spray drying, and sieving were sufficient, and the production scale was 1 in the conventional method. Although the weight was about 150 kg per treatment, the spray-dried granules according to the present invention can be produced in an amount of 2000 kg or more at one time, and continuous production is possible depending on the device. In the present invention, since the step of obtaining the spray-dried granules and the step of adsorbing teprenone are not continuous, and a separate manufacturing machine must be used, no such manufacturing method has been attempted in the past.
The present inventors have intensively studied a more efficient manufacturing method, and the discontinuous manufacturing method that has not been attempted conventionally is superior to the conventional method in addition to man-hours, costs, and the like, In addition, they found that the quality was the same, and completed the present invention.

【0011】[0011]

【実施例】以下に実施例を挙げて本発明を更に詳細に説
明するが、本発明がこれらに限定されるわけではない。
EXAMPLES The present invention will be described in more detail with reference to the following Examples, but it should not be construed that the present invention is limited thereto.

【0012】実施例1 ヒドロキシプロピルセルロース100kg、無水ケイ酸
水加物(商品名サイリシア)250kg、D−マンニト
ール1125kgおよび乳糖712kgを水2187k
gに溶解・分散し、スプレードライヤー3SD機(ノズ
ル型)を用いて噴霧乾燥した。スプレードライ中、溶液
は撹拌を続け、またスプレー速度は毎時400kg、排
風温度は約120℃であった。得られた乾燥粉末を振動
篩により、30メッシュ〜100メッシュ品に篩別し、
その90kgを流動層乾燥機に投入し、流動しながらビ
タミンEを0.2%含有するテプレノン10kgを吸着
させ、本発明にかかるテプレノン含有顆粒を得た。
Example 1 100 kg of hydroxypropylcellulose, 250 kg of anhydrous silicic acid anhydride (trade name: Sylysia), 1125 kg of D-mannitol and 712 kg of lactose were mixed with 2187 k of water.
g, and were spray-dried using a spray dryer 3SD machine (nozzle type). During spray drying, the solution continued to be stirred, the spray speed was 400 kg / h, and the exhaust air temperature was about 120 ° C. The obtained dried powder is sieved into a 30 mesh to 100 mesh product by a vibration sieve,
90 kg thereof was put into a fluidized bed dryer, and 10 kg of teprenone containing 0.2% of vitamin E was adsorbed while flowing to obtain teprenone-containing granules according to the present invention.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】乳糖、マンニトール、二酸化ケイ素及び水
溶性結合剤を水に溶解後噴霧乾燥して得られた顆粒に、
テプレノンを吸着することを特徴とするテプレノン含有
顆粒の製造方法。
[1] A granule obtained by dissolving lactose, mannitol, silicon dioxide and a water-soluble binder in water and then spray-drying,
A method for producing teprenone-containing granules, wherein teprenone is adsorbed.
【請求項2】水2000重量部に対し、乳糖500〜1
000重量部、マンニトール700〜1500重量部、
二酸化ケイ素100〜500重量部及び水溶性結合剤5
0〜150重量部を溶解する請求項1記載のテプレノン
含有顆粒の製造方法。
2. Lactose 500 to 1 with respect to 2000 parts by weight of water.
000 parts by weight, 700-1500 parts by weight of mannitol,
100 to 500 parts by weight of silicon dioxide and water-soluble binder 5
2. The method for producing teprenone-containing granules according to claim 1, wherein 0 to 150 parts by weight are dissolved.
【請求項3】噴霧乾燥して得られた顆粒700〜150
0重量部にテプレノン100重量部を吸着する請求項1
又は2記載のテプレノン含有顆粒の製造方法。
3. Granules 700 to 150 obtained by spray drying.
2. A method for adsorbing 100 parts by weight of teprenone to 0 parts by weight.
Or the method for producing teprenone-containing granules according to 2.
JP25821898A 1998-09-11 1998-09-11 Method for producing teprenone-containing granules Expired - Fee Related JP4226116B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP25821898A JP4226116B2 (en) 1998-09-11 1998-09-11 Method for producing teprenone-containing granules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25821898A JP4226116B2 (en) 1998-09-11 1998-09-11 Method for producing teprenone-containing granules

Publications (2)

Publication Number Publication Date
JP2000086506A true JP2000086506A (en) 2000-03-28
JP4226116B2 JP4226116B2 (en) 2009-02-18

Family

ID=17317165

Family Applications (1)

Application Number Title Priority Date Filing Date
JP25821898A Expired - Fee Related JP4226116B2 (en) 1998-09-11 1998-09-11 Method for producing teprenone-containing granules

Country Status (1)

Country Link
JP (1) JP4226116B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008105971A (en) * 2006-10-24 2008-05-08 Nof Corp Method for producing powder for tableting

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008105971A (en) * 2006-10-24 2008-05-08 Nof Corp Method for producing powder for tableting

Also Published As

Publication number Publication date
JP4226116B2 (en) 2009-02-18

Similar Documents

Publication Publication Date Title
CA1297018C (en) Pharmaceutical composition
JP5714492B2 (en) Granules, methods for their preparation, and pharmaceuticals containing them
JPS6147807B2 (en)
KR930001831B1 (en) Process for the preparation of thiamine salt
JP2007137902A (en) Taste-masked pharmaceutical composition
JP2002529392A (en) Improved rapidly disintegrating tablets
CN86106839A (en) Vitamin-containing granules and process for producing the same
AU765765B2 (en) Particles coated with granulated crystalline ibuprofen
JP2001511453A (en) Pharmaceutical compositions containing vitamin D and calcium, their preparation and use for therapy
JP2002541107A5 (en)
JP2000191516A (en) Solid oral composition
JP2011157385A (en) Method for producing crosslinked gelatin microbeadlet
JPWO2003070023A1 (en) Amino acids powder and method for producing the same
CN1882321B (en) Pellets containing venlafaxine hydrochloride
JP2916227B2 (en) Vitamin B (lower 1) (lower 2)
JP2000086506A (en) Production of granule containing teprenone
KR20030011797A (en) Granulated particles with masked taste
CN106619572A (en) Quinocetone sustained-release pellet and preparation method thereof
JP2002527525A (en) High purity composition containing (7α, 17α) -17-hydroxy-7-methyl-19-nor-17-pregnu-5 (10) -en-20-yn-3-one
JP3372242B2 (en) Sustained release particulate preparation and method for producing the same
JPS5951568B2 (en) Method for producing easily water-soluble polyacrylic acid metal salt granules
JP2006306766A (en) Theophylline sustained-release particulate formulation and its manufacturing method
JPH05139973A (en) Production of nifedipin-containing solid preparation
JP2506812B2 (en) Vitamin E-containing powder with good water dispersibility
JP5164235B2 (en) Unpleasant taste-reducing preparation and production method thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050324

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20060711

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20081125

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20081126

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111205

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111205

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121205

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131205

Year of fee payment: 5

LAPS Cancellation because of no payment of annual fees